Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
about
Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effects.Clinicopathological significance and potential drug target of T-cadherin in NSCLC.Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis.Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing.Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC.Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications.A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.Long noncoding RNA UPAT promoted cell proliferation via increasing UHRF1 expression in non-small cell lung cancer.CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
P2860
Q34407810-1B8178F3-9D63-45F0-A61E-5326F3CC9171Q34783319-3331EB95-4455-4011-AC4B-92BCE3140532Q35229048-8596DB38-05E8-469E-BA84-68AE1C28E50AQ36330501-361D605A-383B-4C5C-ABC0-9758C20B29FDQ36407872-3AD840DD-B587-4751-8F5F-8052D1EB682AQ37708509-10E8F275-DE0D-48E1-87CC-A9C9DF473B2EQ38266450-8889BEA5-7E6F-4D43-BFE1-46B43E51444BQ39108889-471AECB6-2A01-4A03-9923-A5D3295C2BD2Q49165105-C1B1A801-4E00-4F67-AD71-68E44C2866C0Q50033803-62C24F92-241D-43FE-8BCC-65EF991F678DQ53048458-19D4FC85-CE59-43C8-BD6D-3983B93CF38CQ55633259-74001DD9-B8A9-484A-BA0A-3232972CF193Q57788789-39A7452D-8F93-4DDC-86E4-69DE10CA2AFC
P2860
Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@ast
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@en
type
label
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@ast
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@en
prefLabel
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@ast
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@en
P2093
P2860
P1433
P1476
Aberrant promoter methylation ...... non-small-cell lung carcinoma.
@en
P2093
Dragana Jovanovic
Jacquelyn Kuriger
Milica Kontic
Simona Ognjanovic
Susan Puumala
Vera Bunjevacki
P2860
P304
P356
10.1016/J.CLLC.2011.11.003
P407
P577
2011-12-13T00:00:00Z